Detection of interleukin-12 and tumor necrosis factor-α in peritoneal fluid and serum of patients with endometriosis

In: Journal of Zhengzhou University · 2006 · W2364459478
article OA: closed CC0
View on OpenAlex

Abstract

Aim: To study the changes of interleukin-12 (IL-12) and tumor necrosis factor-α (TNF-α)in peritoneal fluid and serum of patients with endometriosis. Methods:IL-12 and TNF-α levels in peritoneal fluid and serum of 26 patients with endometriosis and 16 control cases were detected by enzyme linked immunosorbent assay (ELISA).Results: IL-12 levels in peritoneal fluid and serum of endometriosis group were lower than those in control group. IL-12 levels of both groups in peritoneal fluid were lower than those in serum (P0.01). IL-12 in peritoneal fluid ((19.56±0.83)ng·L -1) and IL-12 in serum ((23.62±0.59)ng·L -1) of stage Ⅲ,Ⅳ in endometriosis group were lower than IL-12 in peritoneal fluid ((23.59±0.56)ng·L -1) and in serum ((28.71±0.54)ng·L -1) of stageⅠ,Ⅱ(both P0.01). TNF-α levels in peritoneal fluid and serum of endometriosis group were higher than those in control group. TNF-α levels of both groups in peritoneal fluid were higher than those in serum (P0.01). TNF-α in peritoneal fluid ((60.24±0.96)ng·L -1) and TNF-α in serum ((49.90±1.36)ng·L -1) of stage Ⅲ,Ⅳ in endometriosis group were higher than TNF-α in peritoneal fluid ((53.37±0.89)ng·L -1) and TNF-α in serum ((42.20±0.99)ng·L -1) of stageⅠ,Ⅱ(both P 0.01).Conclusion: IL-12 and TNF-α play an important role in the pathogenesis of endometriosis. The detection of IL-12 and TNF-α will be helpful in the diagnosis and treatment of this disease.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK